Recently, a novel and highly selective ALDH2 activator, AD-9308, has emerged, demonstrating promising outcomes in addressing diet-induced obesity and fatty liver and enhancing glucose homeostasis in both ALDH2 wild-type and mutation mice (41). The gene discussed is ALDH2; the disease is obesity disorder.